![]() |
|||||||||||||||||
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||||||||
|
![]() |
EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
Volume 9, Number 6, June 2003 Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, MalawiStephen B. Gordon,* Stonard Kanyanda,* Amanda L. Walsh,* Kristy Goddard,*
Mas Chaponda,† Victoria Atkinson,† Wakisa Mulwafu,† Elizabeth M. Molyneux,†
Ed E. Zijlstra,† Malcolm E. Molyneux,* and Steve M. Graham* |
|
|
![]() |
|
Back to article | |
Figure. The cumulative percentage of all pneumococcal isolates plotted by source (see key). Serogroups covered by the 7-valent vaccine are plotted to the left of the heavy vertical line, and the potential 9-valent coverage is illustrated by the dotted vertical line. |
|
|
|
![]() |
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
![]() |
![]() |
This page last reviewed May 13, 2003 |
![]() |
![]() |
Emerging
Infectious Diseases Journal |
![]() |